Clinical Trial Update: Open-label Comparison of Chronocort® Versus Standard Glucocorticoid Replacement Therapy [Phase 3]

View source ↗

Summary

Phase 3 open-label comparison trial of Chronocort versus standard glucocorticoid therapy for congenital adrenal hyperplasia was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Adrenal Hyperplasia

Drugs mentioned

• Chronocort

Snippet

Sponsor: Neurocrine UK Limited | Conditions: Congenital Adrenal Hyperplasia | Phase 3 | Status: WITHDRAWN